• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

MDM2剪接变体P2-MDM2-10和MDM2-∆5在乳腺癌细胞中的功能作用

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells.

作者信息

Huun Johanna, Gansmo Liv B, Mannsåker Bård, Iversen Gjertrud T, Sommerfelt-Pettersen Jan, Øvrebø Jan Inge, Lønning Per E, Knappskog Stian

机构信息

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.

出版信息

Transl Oncol. 2017 Oct;10(5):806-817. doi: 10.1016/j.tranon.2017.07.006. Epub 2017 Aug 29.

DOI:10.1016/j.tranon.2017.07.006
PMID:28844019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5576977/
Abstract

BACKGROUND

MDM2 is a negative regulator of p53 and is upregulated in numerous human cancers. While different MDM2 splice variants have been observed in both normal tissues and malignant cells, their functions are poorly understood.

METHODS

We evaluated the effect of MDM2 splice variants by overexpression in MCF-7 cells and analyses of expression of downstream genes (qPCR and Western blot), subcellular localization (immunofluorescence), cell cycle assays (Nucleocounter3000), apoptosis analysis (Annexin V detection), and induction of senescence (β-galactosidase analysis).

RESULTS

In a screen for MDM2 splice variants in MCF-7 breast cancer cells, extended with data from healthy leukocytes, we found P2-MDM2-10 and MDM2-Δ5 to be the splice variants expressed at highest levels. Contrasting MDM2 full-length protein, we found normal tissue expression levels of P2-MDM2-10 and MDM2-Δ5 to be highest in individuals harboring the promoter SNP309TT genotype. While we detected no protein product coded for by MDM2-Δ5, the P2-MDM2-10 variant generated a protein markedly more stable than MDM2-FL. Both splice variants were significantly upregulated in stressed cells (P=4.3 × 10 and P=7.1 × 10, respectively). Notably, chemotherapy treatment and overexpression of P2-MDM2-10 or MDM2-Δ5 both lead to increased mRNA levels of the endogenous MDM2-FL (P=.039 and P=.070, respectively) but also the proapoptotic gene PUMA (P=.010 and P=.033, respectively), accompanied by induction of apoptosis and repression of senescence.

CONCLUSION

We found P2-MDM2-10 and MDM2-Δ5 to have distinct biological functions in breast cancer cells.

GENERAL SIGNIFICANCE

Alternative splicing may influence the oncogenic effects of the MDM2 gene.

摘要

背景

MDM2是p53的负调控因子，在多种人类癌症中上调。虽然在正常组织和恶性细胞中都观察到了不同的MDM2剪接变体，但其功能尚不清楚。

方法

我们通过在MCF-7细胞中过表达MDM2剪接变体，并分析下游基因的表达（qPCR和蛋白质印迹法）、亚细胞定位（免疫荧光）、细胞周期分析（Nucleocounter3000）、凋亡分析（膜联蛋白V检测）和衰老诱导（β-半乳糖苷酶分析）来评估其作用。

结果

在对MCF-7乳腺癌细胞中的MDM2剪接变体进行筛选，并结合健康白细胞的数据后，我们发现P2-MDM2-10和MDM2-Δ5是表达水平最高的剪接变体。与MDM2全长蛋白相比，我们发现P2-MDM2-10和MDM2-Δ5在正常组织中的表达水平在携带启动子SNP309TT基因型的个体中最高。虽然我们未检测到MDM2-Δ5编码的蛋白质产物，但P2-MDM2-10变体产生的蛋白质明显比MDM2-FL更稳定。两种剪接变体在应激细胞中均显著上调（分别为P = 4.3×10和P = 7.1×10）。值得注意的是，化疗处理以及P2-MDM2-10或MDM2-Δ5的过表达均导致内源性MDM2-FL的mRNA水平升高（分别为P = 0.039和P = 0.070），同时促凋亡基因PUMA的mRNA水平也升高（分别为P = 0.010和P = 0.033），并伴有凋亡诱导和衰老抑制。

结论

我们发现P2-MDM2-10和MDM2-Δ5在乳腺癌细胞中具有不同的生物学功能。

普遍意义

可变剪接可能会影响MDM2基因的致癌作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/d1a438f471e8/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/8ed68a357d2e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/92bde4becf00/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/39474b5bb130/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/73b15724e676/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/4ba8bdac149a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/613b9160b3e7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/a17fa5a391ea/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/08ad5059812f/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/d1a438f471e8/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/8ed68a357d2e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/92bde4becf00/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/39474b5bb130/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/73b15724e676/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/4ba8bdac149a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/613b9160b3e7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/a17fa5a391ea/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/08ad5059812f/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/5576977/d1a438f471e8/gr9.jpg

相似文献

1
The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells.MDM2剪接变体P2-MDM2-10和MDM2-∆5在乳腺癌细胞中的功能作用
Transl Oncol. 2017 Oct;10(5):806-817. doi: 10.1016/j.tranon.2017.07.006. Epub 2017 Aug 29.
2
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.MDM2剪接变体MDM2 - A、MDM2 - B和MDM2 - C对乳腺癌细胞细胞毒性应激反应的影响。
BMC Cell Biol. 2017 Apr 17;18(1):17. doi: 10.1186/s12860-017-0134-z.
3
Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.浸润性乳腺癌中mdm2癌基因的可变及异常信使核糖核酸剪接
Cancer Res. 2001 Apr 1;61(7):3212-9.
4
MDM2 splice variants predominantly localize to the nucleoplasm mediated by a COOH-terminal nuclear localization signal.MDM2剪接变体主要通过羧基末端核定位信号定位于核质。
Mol Cancer Res. 2007 Apr;5(4):403-12. doi: 10.1158/1541-7786.MCR-06-0146.
5
p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.通过多个转录因子反应元件对hdm2 - P2启动子进行p53非依赖性激活，导致雌激素受体α阳性乳腺癌细胞中hdm2表达升高。
Cancer Res. 2003 May 15;63(10):2616-23.
6
Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.在槟榔和烟草相关的人类口腔癌中，MDM2 - P2转录本的诱导与稳定的野生型p53相关。
Am J Pathol. 2000 Aug;157(2):587-96. doi: 10.1016/S0002-9440(10)64569-5.
7
Distinct promoter usage of mdm2 gene in human breast cancer.人类乳腺癌中mdm2基因独特的启动子使用情况。
Oncol Rep. 2002 May-Jun;9(3):557-63.
8
25-Hydroxyvitamin D3 1alpha-hydroxylase splice variants in breast cell lines MCF-7 and MCF-10.乳腺癌细胞系MCF - 7和MCF - 10中的25 - 羟基维生素D3 1α - 羟化酶剪接变体
Cancer Genomics Proteomics. 2007 Jul-Aug;4(4):295-300.
9
Novel MDM2 splice variants identified from oral squamous cell carcinoma.从口腔鳞状细胞癌中鉴定出新型 MDM2 剪接变异体。
Oral Oncol. 2012 Nov;48(11):1128-35. doi: 10.1016/j.oraloncology.2012.05.016. Epub 2012 Jun 15.
10
MDM2 splice variants and their therapeutic implications.MDM2剪接变体及其治疗意义。
Curr Cancer Drug Targets. 2005 Feb;5(1):21-6. doi: 10.2174/1568009053332654.

引用本文的文献

1
Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in and genes in Sardinian women.撒丁岛女性中BRCA1和BRCA2基因常见基因多态性对乳腺癌易感性及临床病理特征的影响。
Oncol Lett. 2022 Aug 8;24(4):331. doi: 10.3892/ol.2022.13451. eCollection 2022 Oct.
2
Extracellular circulating miRNAs as stress-related signature to search and rescue dogs.细胞外循环 miRNA 作为与应激相关的生物标志物用于搜救犬。
Sci Rep. 2022 Feb 25;12(1):3213. doi: 10.1038/s41598-022-07131-5.

本文引用的文献

1
Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon.MDM2基因SNP309和SNP285状态对乳腺癌、前列腺癌、肺癌和结肠癌发病风险的影响。
Int J Cancer. 2015 Jul 1;137(1):96-103. doi: 10.1002/ijc.29358. Epub 2014 Dec 10.
2
MDM2, MDMX and p53 in oncogenesis and cancer therapy.MDM2、MDMX 和 p53 在肿瘤发生和癌症治疗中的作用。
Nat Rev Cancer. 2013 Feb;13(2):83-96. doi: 10.1038/nrc3430. Epub 2013 Jan 10.
3
Novel MDM2 splice variants identified from oral squamous cell carcinoma.从口腔鳞状细胞癌中鉴定出新型 MDM2 剪接变异体。
Oral Oncol. 2012 Nov;48(11):1128-35. doi: 10.1016/j.oraloncology.2012.05.016. Epub 2012 Jun 15.
4
MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk.MDM2 启动子 SNP344T>A（rs1196333）状态不影响癌症风险。
PLoS One. 2012;7(4):e36263. doi: 10.1371/journal.pone.0036263. Epub 2012 Apr 30.
5
SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer.SNP285C 调节雌激素受体/Sp1 与 MDM2 启动子的结合，降低子宫内膜癌但不增加前列腺癌的风险。
Eur J Cancer. 2012 Sep;48(13):1988-96. doi: 10.1016/j.ejca.2011.10.024. Epub 2011 Nov 24.
6
The evolution of MDM2 family genes.MDM2 家族基因的进化。
Gene. 2011 Oct 15;486(1-2):23-30. doi: 10.1016/j.gene.2011.06.030. Epub 2011 Jul 4.
7
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.MDM2 启动子 SNP285C/309G 单倍型降低了 Sp1 转录因子的结合，并降低了白种人患乳腺癌和卵巢癌的风险。
Cancer Cell. 2011 Feb 15;19(2):273-82. doi: 10.1016/j.ccr.2010.12.019.
8
The C terminus of p53 binds the N-terminal domain of MDM2.p53 的 C 端与 MDM2 的 N 端结构域结合。
Nat Struct Mol Biol. 2010 Aug;17(8):982-9. doi: 10.1038/nsmb.1872. Epub 2010 Jul 18.
9
Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis.MDM2 SNP309 多态性对乳腺癌风险的种族差异影响：荟萃分析。
Breast Cancer Res Treat. 2010 Feb;120(1):211-6. doi: 10.1007/s10549-009-0467-1. Epub 2009 Jul 10.
10
Disruption of the p53-Mdm2 complex by Nutlin-3 reveals different cancer cell phenotypes.Nutlin-3对p53-Mdm2复合物的破坏揭示了不同的癌细胞表型。
Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-1-8.